Exhibit 99.1
Selected Financial Data
The following table sets forth our selected consolidated financial data as of and for the years ended September 30, 2010, 2009, 2008, 2007 and 2006.
Year Ended September 30, | ||||||||||||||||||||
2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||
Consolidated Statement of Operations Data: | ||||||||||||||||||||
(in thousands, except per share data) | ||||||||||||||||||||
Net revenue | $ | 365,486 | $ | 327,204 | $ | 319,699 | $ | 379,577 | $ | 357,386 | ||||||||||
Impairment of long-lived assets and goodwill | $ | 66,022 | $ | 42,000 | $ | — | $ | — | $ | 458 | ||||||||||
(Loss) income from continuing operations before income taxes | $ | (65,960 | ) | $ | (34,353 | ) | $ | 26,047 | $ | 29,296 | $ | (937 | ) | |||||||
(Loss) income from continuing operations, net of taxes | $ | (39,687 | ) | $ | (33,307 | ) | $ | 20,127 | $ | 8,364 | $ | (8,178 | ) | |||||||
Income from discontinued operations, net of taxes | $ | 3,705 | $ | 552 | $ | 22,721 | $ | 3,163 | $ | 19,634 | ||||||||||
Net (loss) income | $ | (48,371 | ) | $ | (50,282 | ) | $ | 20,990 | $ | 11,527 | $ | 12,576 | ||||||||
(Loss) earnings from continuing operations attributable to MedCath Corporation common stockholders per share, basic | $ | (2.55 | ) | $ | (2.17 | ) | $ | 0.34 | $ | 0.40 | $ | (0.44 | ) | |||||||
(Loss) earnings from continuing operations attributable to MedCath Corporation common stockholders per share, diluted | $ | (2.55 | ) | $ | (2.17 | ) | $ | 0.34 | $ | 0.39 | $ | (0.42 | ) | |||||||
(Loss) earnings per share, basic | $ | (2.44 | ) | $ | (2.55 | ) | $ | 1.05 | $ | 0.56 | $ | 0.67 | ||||||||
(Loss) earnings per share, diluted | $ | (2.44 | ) | $ | (2.55 | ) | $ | 1.04 | $ | 0.54 | $ | 0.64 | ||||||||
Weighted average number of shares, basic | 19,842 | 19,684 | 19,996 | 20,872 | 18,656 | |||||||||||||||
Weighted average number of shares, diluted | 19,842 | 19,684 | 20,069 | 21,511 | 19,555 | |||||||||||||||
Balance Sheet and Cash Flow Data: | ||||||||||||||||||||
(in thousands) | ||||||||||||||||||||
Total assets | $ | 494,538 | $ | 590,448 | $ | 653,456 | $ | 678,567 | $ | 785,849 | ||||||||||
Total long-term obligations | $ | 99,841 | $ | 115,063 | $ | 121,875 | $ | 148,484 | $ | 274,962 | ||||||||||
Net cash provided by operating activities | $ | 43,294 | $ | 63,633 | $ | 52,008 | $ | 58,225 | $ | 65,634 | ||||||||||
Net cash (used in) provided by investing activities | $ | (16,956 | ) | $ | (63,790 | ) | $ | (5,805 | ) | $ | (28,591 | ) | $ | 10,064 | ||||||
Net cash used in financing activities | $ | (41,009 | ) | $ | (50,210 | ) | $ | (78,028 | ) | $ | (80,116 | ) | $ | (22,165 | ) | |||||
Selected Operating Data (consolidated) (a): | ||||||||||||||||||||
Number of hospitals | 5 | 4 | 4 | 4 | 5 | |||||||||||||||
Licensed beds (b) | 466 | 396 | 332 | 244 | 356 | |||||||||||||||
Staffed and available beds (c) | 380 | 310 | 272 | 242 | 354 | |||||||||||||||
Admissions (d) | 18,762 | 15,836 | 17,010 | 22,494 | 23,789 | |||||||||||||||
Adjusted admissions (e) | 28,163 | 23,301 | 23,274 | 31,510 | 32,806 | |||||||||||||||
Patient days (f) | 69,956 | 60,763 | 61,259 | 75,751 | 79,651 | |||||||||||||||
Adjusted patient days (g) | 105,467 | 89,281 | 83,541 | 105,680 | 109,670 | |||||||||||||||
Average length of stay (h) | 3.73 | 3.84 | 3.60 | 3.37 | 3.35 | |||||||||||||||
Occupancy (i) | 50.4 | % | 53.7 | % | 61.7 | % | 85.8 | % | 61.6 | % | ||||||||||
Inpatient catheterization procedures (j) | 7,986 | 7,348 | 9,048 | 10,481 | 10,372 | |||||||||||||||
Inpatient surgical procedures (k) | 4,555 | 4,200 | 3,975 | 5,154 | 5,321 | |||||||||||||||
Hospital net revenue | $ | 362,552 | $ | 324,286 | $ | 316,389 | $ | 375,037 | $ | 351,669 |